Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | ESR1 | P03372 | 2/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.52 |
| ▸ | TACR2 | P21452 | 2/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | SHBG | P04278 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.52 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL673425 | 1.00 | CYP3A4 (0.55) | CYP3A4TSHRESR1ADRA2AADORA3 | |
| SCHEMBL991821 | 1.00 | CYP3A4 (0.55) | CYP3A4TSHRESR1ADRA2AADORA3 | |
| SCHEMBL5885578 | 1.00 | CYP3A4 (0.55) | CYP3A4TSHRESR1ADRA2AADORA3 | |
| SCHEMBL2488182 | 1.00 | CYP3A4 (0.55) | CYP3A4TSHRESR1ADRA2AADORA3 | |
| SCHEMBL13725699 | 1.00 | CYP3A4 (0.55) | CYP3A4TSHRESR1ADRA2AADORA3 | |
| SCHEMBL5884680 | 1.00 | CYP3A4 (0.55) | CYP3A4TSHRESR1ADRA2AADORA3 | |
| SCHEMBL5885475 | 1.00 | CYP3A4 (0.55) | CYP3A4TSHRESR1ADRA2AADORA3 | |
| SCHEMBL10400983 | 1.00 | CYP3A4 (0.55) | CYP3A4TSHRESR1ADRA2AADORA3 | |
| SCHEMBL1403683 | 0.98 | CYP3A4 (0.57) | CYP3A4TSHRESR1ADRA2AADORA3 | |
| SCHEMBL14565823 | 0.95 | CYP3A4 (0.65) | CYP3A4TSHRESR1ADRA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509547-B2 | Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component | BASF SE (DE) | 2025-12-30 | — | — | US | claimed |
| US-20230348657-A1 | SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT | BASF SE (DE) | 2023-11-02 | — | — | US | claimed |
| EP-4185626-A1 | SYNTHESIS OF LINEAR POLYOXAZOLIDINONES USING URETDIONES AS DIISOCYANATE COMPONENT | BASF SE (DE) | 2023-05-31 | — | — | EP | claimed |
| CN-116137864-A | Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component | 巴斯夫欧洲公司 | 2023-05-19 | — | — | CN | claimed |
| CN-112996835-B | Method for producing thermoplastic polyoxazolidone polymers | 科思创知识产权两合公司 | 2022-12-13 | — | — | CN | claimed |
| EP-3873961-B1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-08-17 | — | — | EP | claimed |
| US-11370874-B2 | Method for the production of thermoplastic polyoxazolidone polymers | COVESTRO DEUTSCHLAND AG (DE) | 2022-06-28 | — | — | US | claimed |
| EP-3681924-B1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-05-18 | — | — | EP | claimed |
| EP-3873962-B1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE POLYMERS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-05-18 | — | — | EP | claimed |
| US-11326018-B2 | Process for the synthesis of polyoxazolidinone compounds | COVESTRO DEUTSCHLAND AG (DE) | 2022-05-10 | — | — | US | claimed |
| WO-2018141743-A1 | METHOD FOR THE PRODUCTION OF POLYOXAZOLIDINONE POLYMER COMPOUNDS | COVESTRO DEUTSCHLAND AG (DE) | 2018-08-09 | — | — | WO | claimed |
| EP-3357949-A1 | METHOD FOR THE PRODUCTION OF POLYOXAZOLIDINONE POLYMER COMPOUNDS | Covestro Deutschland AG (DE) | 2018-08-08 | — | — | EP | claimed |
| US-10040808-B2 | Silane-modified formamides | COVESTRO DEUTSCHLAND AG (DE) | 2018-08-07 | — | — | US | claimed |
| WO-2018033562-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS | COVESTRO DEUTSCHLAND AG (DE) | 2018-02-22 | — | — | WO | claimed |
| US-20180022871-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2018-01-25 | — | — | US | claimed |
| EP-3256508-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | Covestro Deutschland AG (DE) | 2017-12-20 | — | — | EP | claimed |
| WO-2016128380-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2016-08-18 | — | — | WO | claimed |
| EP-0204118-B1 | POLYAMIDE MODIFIED BY A MONOISOCYANATE | BAYER AG (DE) | 1990-06-06 | — | — | EP | claimed |
| US-4918148-A | IMPROVED FLOWABILITY, MOLD RELEASE AND-OR NOTCHED IMPACT STRENGTH | BAYER AKTIENGESELLSCHAFT (DE) | 1990-04-17 | — | — | US | claimed |
| EP-0204118-A1 | Polyamide modified by a monoisocyanate | BAYER AG (DE) | 1986-12-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509547-B2 | Synthesis of linear polyoxazolidinones using uretdiones as diisocyanate component | BMP1, BMP4, PBRM1 | CYP3A4 1801/4885TSHR 4875/4885ESR1 2246/4885 |
| US-10040808-B2 | Silane-modified formamides | PFAS, ITGA8, CAD | CYP3A4 3614/4885TSHR 4875/4885ESR1 1219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.